CCI-779 in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Randomized phase II trial to compare the effectiveness of different doses of CCI-779 in
treating patients who have extensive-stage small cell lung cancer. Drugs used in chemotherapy
use different ways to stop tumor cells from dividing so they stop growing or die